Publications by authors named "Sadru Kabani"

Objective: We report the first 4 cases of intraoral nonnecrotizing granulomatous foreign body reactions to diatoms, plausibly as a result of exogenous material introduced following iatrogenic or traumatic injury.

Study Design: Clinical and histopathologic findings of 4 intraoral cases of nonnecrotizing granulomatous foreign body reaction to diatoms, single-celled algae belonging to the taxonomic phylum Bacillariophyta, are reported.

Results: The lesions presented either in the jaws or in the soft tissue overlying the alveolar bone, in some instances mimicking an inflammatory lesion of odontogenic etiology.

View Article and Find Full Text PDF

We report 7 cases of hitherto undescribed keratotic papillary plaques of uncertain etiology involving the gingiva. All 7 cases presented on the anterior maxillary attached gingiva of patients in the second decade. The lesions were asymptomatic and 86% (6 of 7 cases) presented in a bilateral symmetric distribution.

View Article and Find Full Text PDF
Article Synopsis
  • * A study presented four new cases of oral LPP, with three patients showing only oral symptoms, and biopsies revealing characteristics of both lichen planus and mucous membrane pemphigoid.
  • * Key to diagnosing LPP is the integration of clinical observations, histological examination, and direct immunofluorescence tests that confirmed the presence of immunoglobulin G and C3 deposits.
View Article and Find Full Text PDF

Objective: We report intraoral granulomatous foreign body reactions in patients treated with calcium hydroxylapatite (CHA) or poly-l-lactic acid (PLA).

Study Design: Clinical and histopathologic data were obtained from 25 patients who developed orofacial nodules or swelling after dermal filler injections.

Results: All 25 patients were women aged 35 to 78 years (median, 55 years).

View Article and Find Full Text PDF

Imatinib mesylate (STI-571, Gleevec(®)), a tyrosine kinase inhibitor, is a first-line medication for treating chronic myeloid leukemia (CML). Clinical studies revealed very good hematological responses without significant side effects. However, imatinib may lead to mucosal pigmentation.

View Article and Find Full Text PDF